• Phone
  • Contact us
  • Locations
  • Search
  • Menu

share

  • Add this article to your LinkedIn page
  • Add this article to your Twitter feed
  • Email this article
View or print a PDF of this page
.
Close this video
 

Unlocking commercial potential in pharma

Explore more below:

Healthcare landscapesThe value of big dataSales and marketingTransforming organisations

New strategy and business models for the future of the pharmaceutical industry

In today’s pharmaceutical industry, there is only so far that traditional approaches can be pushed to drive new revenue. To help you navigate the changing pharma landscape, our team brings deep insight across life sciences, healthcare, medtech and government. We combine this with specific capabilities in patient profiling and real world data; commercial strategy; and pharma business design.

Our work has created exceptional results for pharma companies worldwide. In Europe, we worked with the regional business of a multinational drugs company to build and launch a key account management facility. This is helping this pharma business meet the rapidly changing needs and expectations of their customer base. We also worked with a global pharma business to create a strategy that will transform them from a product-centric organisation into a strategic partner in the delivery of improved patient outcomes. Central to our work in the pharmaceutical industry has been the establishment of strong relationships between the company and the systems and networks that dominate the pharma market today.

To find out more about unlocking commercial potential in your pharma organisation, contact us now

How do you unlock your commercial potential? [d49Pn3ffDl8]

Explore more below:

Healthcare landscapesThe value of big dataSales and marketingTransforming organisationsHome

We have the knowledge and insight to navigate the new healthcare landscape

The uncertain economic climate presents new challenges for life sciences companies worldwide. Pharma businesses must contend with falling revenues and evolving regulatory requirements. High expenditure is increasing the need for cost containment, driven in part by sweeping reforms such as Obamacare in the US. In parallel, new customer and patient trends – including the shift from hospital to primary care – are growing rapidly, creating new opportunities.

Our teams bring together varied insight across global healthcare, life sciences and government. We combine our experience of these industries with specialist capability that covers strategy, digital business and people management.

We are helping global pharma firms structure their businesses and develop new operating models that better fit the market. We are giving them the expertise and fresh thinking to find – and fill – the gaps in their capabilities. And we are helping them achieve successful market access and stronger stakeholder relationships. We clarify what the changing landscape means for you, now and in the immediate future.

To find out more about unlocking commercial potential in your organisation, contact us now

We have the tools and technology to mine real world data to improve patient outcomes

Across sectors, the explosion of real world data presents an array of new opportunities. In the life sciences industry, pharma companies can improve outcomes through sophisticated patient profiling. Drawing on data analysis, they can model and predict patterns of demand. They can monitor and respond to the real outcomes of drug usage. 

We combine detailed knowledge of healthcare and life sciences with specific capabilities across big data. We have extensive experience of mining commercial value through business intelligence. To this end, we are working with global pharma businesses to help them understand – and react to – the needs of medical groups, prescribers and patients. We are helping them use longitudinal patient data – whether electronic medical data, pharmacy records or physician surveys – to make smarter decisions about new products and to track patient treatments over time.

To find out more about unlocking commercial potential in your organisation, contact us now

We improve the impact of sales and marketing channels, teams and processes

In recent years, the pharma market has changed substantially. The traditional sales approach was to provide product information to physicians around the efficacy of individual drugs. While this approach continues in some areas, the availability of generic medicines and a change in focus towards patient outcomes has created the need for alternative methods.

We work with pharma companies to help them understand new consumer trends and develop innovative customer value propositions. We recently helped a major pharma business evolve their commercial selling model to meet the changing needs of customers. An important element of this lay in developing a key account management capability. We helped train their people to create more consistent customer engagement and a more effective value proposition.

At the same time, we are working with a range of pharma companies to help them develop multichannel strategies across both digital and physical channels. We worked with a global drug company to up-skill their people and develop digital content to achieve a shift in market access.

To find out more about unlocking commercial potential in your organisation, contact us now

We design and implement life science organisations that are adapted to new demands

To meet a range of demands – from healthcare reform to the extinction of the blockbuster – pharma companies need the right strategy and the right organisation to make it happen. They need the capability to create value and intelligence through real world data. And they need a smart and responsive approach to market.

Drawing on industry experience and strategic insight, we work with companies to deliver exceptional results. Together, we create organisations that mobilise the right people to realise the strategy, delivering profits while constraining cost.

We helped a global pharma company create a strategy that will transform them from a product-centric organisation into a strategic partner in the delivery of improved patient outcomes. Central to our work has been the establishment of strong relationships between the company and the health systems and medical groups that dominate healthcare. In Europe, we worked with the regional business of a multinational drugs company to build and launch a key account management facility that is delivering lasting success.

To find out more about unlocking commercial potential in your organisation, contact us now

Healthcare landscape

New strategy and business models for the future of the life sciences industry

In today’s pharmaceuticals industry, there is only so far that traditional approaches can be pushed to drive new revenue. To help you navigate the changing landscape, our team brings deep insight across life sciences, healthcare, medtech and government. We combine this with specific capabilities in patient profiling and real world data; commercial strategy; and pharma business design.

PAnorama Commercial Potential TG
/our-thinking/unlocking-commercial-potential-in-pharma/
http://www.paconsulting.com/our-thinking/unlocking-commercial-potential-in-pharma/
http://www.paconsulting.com/our-thinking/unlocking-commercial-potential-in-pharma/ucpp/

By using this website, you accept the use of cookies. For more information on how to manage cookies, please read our privacy policy.

×